The estimated Net Worth of Christopher M Fashek is at least $48.4 ezer dollars as of 15 June 2022. Christopher Fashek owns over 40,000 units of NanoVibronix Inc stock worth over $48,360 and over the last 8 years he sold NAOV stock worth over $0. In addition, he makes $0 as Chairman of the Board at NanoVibronix Inc.
Sign up
Christopher Fashek NAOV stock SEC Form 4 insiders trading
Christopher has made over 3 trades of the NanoVibronix Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he bought 40,000 units of NAOV stock worth $24,000 on 15 June 2022.
The largest trade he's ever made was buying 40,000 units of NanoVibronix Inc stock on 15 June 2022 worth over $24,000. On average, Christopher trades about 6,818 units every 85 days since 2016. As of 15 June 2022 he still owns at least 75,000 units of NanoVibronix Inc stock.
You can see the complete history of Christopher Fashek stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Christopher Fashek biography
Christopher Fashek is the Chairman of the Board at NanoVibronix Inc.
What's Christopher Fashek's mailing address?
Christopher's mailing address filed with the SEC is C/O NANOVIBRONIX, INC., 525 EXECUTIVE BOULEVARD, ELMSFORD, NY, 10523.
Insiders trading at NanoVibronix Inc
Over the last 8 years, insiders at NanoVibronix Inc have traded over $0 worth of NanoVibronix Inc stock and bought 131,000 units worth $98,060 . The most active insiders traders include Christopher M Fashek, Thomas Mika és Harold Jacob. On average, NanoVibronix Inc executives and independent directors trade stock every 190 days with the average trade being worth of $14,078. The most recent stock trade was executed by Thomas Mika on 5 January 2023, trading 50,000 units of NAOV stock currently worth $12,500.
What does NanoVibronix Inc do?
nanovibronix inc. is a medical device company that is focused on creating medical products utilizing its proprietary low intensity acoustic technology. the company's patented technology allows for creation of miniature transducers that transmit low-frequency, low-intensity ultrasound through flexible material surfaces. this unique development may be utilized for a variety of medical requiring low cost therapeutic ultrasound applications. the company's patch based product diagnosis, painshield®, carries an fda clearance. nanovibronix catheter based products include the cathbottm . nanovibronix inc. is located in elmsford, ny. its subsidiary, nanovibronix ltd. is located in nesher, israel.
What does NanoVibronix Inc's logo look like?
Complete history of Christopher Fashek stock trades at NanoVibronix Inc
NanoVibronix Inc executives and stock owners
NanoVibronix Inc executives and other stock owners filed with the SEC include:
-
Brian M. Murphy,
CEO & Director -
Stephen R. Brown CPA, CPA,
CFO & Accounting Officer -
Harold Jacob,
Chief Medical Officer, Director -
Stephen Brown,
Chief Financial Officer -
Thomas Mika,
Independent Director -
Michael Ferguson,
Independent Director -
Martin Goldstein,
Director -
Brian Murphy,
Chief Executive Officer, Director -
William Stern,
President -
Christopher Fashek,
Chairman of the Board -
Dr. Harold Jacob M.D.,
Chief Medical Officer & Director -
Lindsey Harrison,
VP of Sales -
Amir Rippel,
VP of Marketing -
Ira A Greenstein,
Director -
Maria Schroeder,
Director -
Aurora Cassirer,
Director